You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Ubiquitin antibody (ab19247)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab19247? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab19247 has been referenced in 7 publications.

  1. Yang F et al. BubR1 Is Modified by Sumoylation during Mitotic Progression. J Biol Chem 287:4875-82 (2012). WB; Human. PubMed: 22167194
  2. Azzu V & Brand MD Degradation of an intramitochondrial protein by the cytosolic proteasome. J Cell Sci 123:578-85 (2010). IP. PubMed: 20103532
  3. Polito VA et al. Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy. Hum Mol Genet 19:4871-85 (2010). IHC-P; Mouse. PubMed: 20876612
  4. Fishman-Jacob T et al. A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A. J Biol Chem 284:32835-45 (2009). ICC/IF; Mouse. PubMed: 19748892
  5. Foo RS et al. Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2. J Biol Chem 282:5529-35 (2007). PubMed: 17142834
  6. Reiterer G & Yen A Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res 67:7765-72 (2007). PubMed: 17699781
  7. Thomas AV et al. Interaction between presenilin 1 and ubiquilin 1 as detected by fluorescence lifetime imaging microscopy and a high-throughput fluorescent plate reader. J Biol Chem 281:26400-7 (2006). PubMed: 16815845

Publishing research using ab19247? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"